ARTL
NASDAQ
$1.12
Artelo Biosciences Inc (ARTL)
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $18 (+1507.14%)
Market Cap
$2.75M
P/B Ratio
0.76
Beta (5Y)
0.02
Price Chart
Valuation
Market Cap$2.75M
P/B0.76
Profitability
EBITDA-$13M
EPS-$10.95
Growth & Risk
EPS 5Y CAGR-8.64%
FCF 5Y CAGR+13.91%
Beta (5Y)0.02
Sharpe Ratio-0.56